Anfield Capital Management »

Fs Global Cr Opportunitie Fda shares owned by Anfield Capital Management

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Anfield Capital Management from 13F filings

Historical chart of Anfield Capital Management investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Anfield Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Anfield Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $95k 17k 5.67
2023-09-30 $90k 17k 5.42
2023-06-30 $79k 17k 4.75
2023-03-31 $49k 11k 4.44

More positions owned by Anfield Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Communication Services Select Sector Spdr Fund Communication (XLC)
Two Rds Shared Tr Anfield Us Equ (AESR)
Vaneck Semiconductor Etf Semiconductor Et (SMH)
Technology Select Sector Spdr Fund Technology (XLK)
Consumer Discretionary Select Sector Spdr Fund Sbi Cons Discr (XLY)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Health Care Select Sector Spdr Fund Sbi Healthcare (XLV)
Ishares Us Treasury Bond Etf Us Treas Bd Etf (GOVT)
Invesco Fundamental High Yield Corporate Bond Etf Fndmntl Hy Crp (PHB)
Industrial Select Sector Spdr Fund Sbi Int-inds (XLI)
First Tr Exchng Traded Fd Vi Ft Cboe Vest Bfr (FJAN)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Spdr Index Shs Fds Euro Stoxx 50 (FEZ)
Spdr Ser Tr Bloomberg Brclys (JNK)

View all positions for Anfield Capital Management

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Saba Capital Management
Wagner Wealth Management
Penserra Capital Management
Advisor Group Holdings
H D Vest Advisory Services
Rockefeller Capital Management
Royal Bank of Canada
Kestra Advisory Services
Ellis Investment Partners
Prime Capital Investment Advisors
Feltz Wealth PLAN

View all funds holding Fs Global Cr Opportunitie Fda